Ganse Apothecary Llc
Specialty Pharmacy
21 N Charlotte St, Lancaster
Pennsylvania, 17603-3702
717-394-5671 717-394-4566
Ganse Apothecary Llc is an authorized DME supplier for medicare equipments and products.
Ganse Apothecary Llc is a Specialty Pharmacy in Lancaster, Pennsylvania. It is located at 21 N Charlotte St, Lancaster and it's customer support contact number is 717-394-5671. The authorized person of Ganse Apothecary Llc is Greg Ganse who is Chief Executive Officer of the pharmacy and his contact number is 717-394-5671. Ganse Apothecary Llc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Ganse Apothecary Llc is a pharmacy that dispenses generally low volume and high cost medicinal preparations to patients who are undergoing intensive therapies for illnesses that are generally chronic, complex and potentially life threatening. Often these therapies require specialized delivery and administration.
Pharmacy Details:
Ganse Apothecary Llc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Ganse Apothecary Llc |
| Type: | Specialty Pharmacy |
| Location: | 21 N Charlotte St, Lancaster, Pennsylvania, 17603-3702 |
| Phone: | 717-394-5671 |
| Fax: | 717-394-4566 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Greg Ganse |
| Position: | Chief Executive Officer |
| Contact Number: | 717-394-5671 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1558395533 |
| NPI Enumeration Date: | 10 Jul, 2006 |
| NPI Last Update On: | 30 Sep, 2024 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ganse Apothecary Llc are as mentioned below.
| Specialization | License Number | State | Status | |
| Specialty Pharmacy | | | Primary | |
| Community/Retail Pharmacy | PP410289L | Pennsylvania | Secondary | |
| Long Term Care Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 3909706 | Other | Pennsylvania | Ncpdp |
| 0005831360002 | Medicaid | Pennsylvania | |
Medicare Enrollment:
Ganse Apothecary Llc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 3870605579 | O20100930091789 | Ganse Apothecary | DME SUPPLIER - PHARMACY |
Products Available:
Ganse Apothecary Llc has following products available for sale under medicare.
| Products: |
|---|
| • Blood Glucose Monitors & Supplies: Non-mail Order | • Enteral Equipment And/or Supplies |
| • Enteral Nutrients | • Ostomy Supplies |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 355 W King St, Lancaster, Pennsylvania |
| Zip: | 17603-3751 |
| Phone Number: | 717-394-5671 |
| Fax Number: | 717-394-4566 |
Patients can reach Ganse Apothecary Llc at
21 N Charlotte St, Lancaster, Pennsylvania or can
call on customer care at 717-394-5671.
Comments/ Reviews:
Read all the reviews posted for Ganse Apothecary Llc below. You may also share your own experience with Ganse Apothecary Llc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.